GeoVax
Smyrna
About GeoVax
GeoVax Labs operates as a biotechnology company focusing on developing vaccines that prevent and fight human immunodeficiency virus (HIV) infections that result in acquired immunodeficiency syndrome (AIDS). It was founded in 1988 and is based in Smyrna, Georgia, United States.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $86.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2025)
- Ticker: nasdaq:GOVX
- Website: geovax.com
- Phone: 6783847281
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/geovax-114974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.